Safety Considerations and Who May Benefit Whilst GLP-1 receptor agonists are generally well-tolerated, understanding their adverse effect profile is essential for appropriate patient selection and monitoring
Androgenetic alopecia required ongoing treatment, but with her medication regimen, she maintained good hair density
Patients with a medullary thyroid cancer history or MEN2 should avoid them unless advised by a provider
Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis in adults with excessive scar tissue in the liver
Specifically, prebiotic fibers like resistant starch and beta-glucan support the production of short-chain fatty acids (SCFA), which stimulate your intestinal cells to release GLP-1
Extended Use Considerations Clinical trials ran for 48 weeks, demonstrating safety and continued efficacy over longer durations